SS Innovations International Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has appointed veteran medical technology finance executive Sarah M. Romano as chief financial officer, effective August 3, 2026. The appointment adds significant public-company financial and capital markets experience as the company continues its global expansion and advances regulatory initiatives for its SSi Mantra robotic surgical platform.
Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised more than $100 million during her career. She joins SS Innovations after serving as chief financial officer at Vicarious Surgical, another developer of robotic surgical technologies, where she oversaw financial and operational initiatives designed to reduce cash burn and strengthen the company’s balance sheet.
The appointment comes at a pivotal time for SS Innovations, which is pursuing broader commercialization of its SSi Mantra surgical robotic system while continuing preparations for U.S. Food and Drug Administration review (https://nnw.fm/yY4UM). The company's recent international expansion efforts include graduating the inaugural class of its SS International Centre for Robotics Surgery (SSICRS) cardiac robotic surgery training program. SSICRS welcomed 33 healthcare professionals from seven countries, underscoring the company’s emphasis on surgeon education alongside technology deployment.
The addition of Romano strengthens the leadership team as the company navigates the regulatory pathway in the U.S. and expands its footprint globally. Her experience in capital markets and financial management will be critical in supporting the company's growth strategy, which includes not only regulatory approvals but also building a trained surgeon base to adopt the technology.
The implications for the industry are significant: successful FDA clearance of the SSi Mantra could introduce a new competitor in the U.S. surgical robotics market, potentially increasing access to robotic-assisted surgery and driving innovation. The training program's international reach also suggests that SS Innovations is building a global ecosystem to support adoption, which could accelerate the spread of robotic surgery in emerging markets.
For investors, the appointment of a seasoned CFO like Romano signals a focus on financial discipline and strategic capital management, which could be key to sustaining the company's growth trajectory. The company's newsroom (https://nnw.fm/SSII) provides the latest updates on its progress.
